Filing Details

Accession Number:
0001104659-22-052419
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-04-28 17:23:55
Reporting Period:
2022-04-26
Accepted Time:
2022-04-28 17:23:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1442836 Mersana Therapeutics Inc. MRSN Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1645755 Alejandra Carvajal C/O Mersana Therapeutics, Inc.
840 Memorial Drive
Cambridge MA 02139
Chief Legal Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-04-26 13,250 $0.00 13,250 No 4 M Direct
Common Stock Disposition 2022-04-26 3,948 $3.69 9,302 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted stock unit Disposition 2022-04-26 13,250 $0.00 13,250 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
13,250 No 4 M Direct
Footnotes
  1. Represents shares of common stock received upon the vesting of a portion of the restricted stock units ("RSUs") awarded to the Reporting Person on April 26, 2021.
  2. Represents the sale of shares of common stock to satisfy the Reporting Person's tax withholding obligations in connection with the service-based vesting and settlement of the RSUs.
  3. Each RSU represents the contingent right to receive one share of common stock of the Issuer.
  4. The RSUs vested as to 50% of the shares on April 26, 2022 and will vest as to 50% of the shares on April 26, 2023, subject to the Reporting Person's continued service to the Issuer on such date.